It has been suggested that iron-deficient rats have lower bone mass than iron-replete animals, but a clear association between bone and iron repletion has not been demonstrated in humans. A growing body of evidences also suggests a relation between lipid oxidation and bone metabolism and between iron metabolism and LDL oxidation. Iron availability to cells also depends on haptoglobin (Hp) phenotypes. Hp has also important antioxidant properties according to its phenotype, hence we evaluate whether Hp phenotype could influence bone density, iron metabolism and lipid oxidation. This cross-sectional study enrolled 455 postmenopausal women affected by osteoporosis (260) or not (195). Bone mineral density, markers of bone and iron metabolism, levels of oxidized LDL (oxLDL) and Hp phenotype were measured in all the subjects. Hp 1.1 and 2.2 frequency was higher and Hp 2.1 was lower in the patients with fragility fractures (80) compared with the controls. We therefore evaluate different Hp phenotypes as risk or protective factors against fragility fracture: Hp 2.1 is a protective factor against fracture while 1.1 is an important and 2.2 a moderate risk factor for fragility fractures. Lower serum iron was associated with elevated transferrin in patients with Hp 1.1; moreover patients had relative iron deficiency compared with the controls and fractured patients had higher level of oxLDL. We found that both iron metabolism and oxLDL varies according to Hp phenotypes and are predictive of bone density. Our data indicate that Hp 2.1 is a protective factor for fragility fractures, depending on its role on iron metabolism and its antioxidant properties.

Role of iron metabolism and oxidative damage in postmenopausal bone loss

D'AMELIO, Patrizia;ISAIA, Giovanni Carlo;PONZETTO, Antonio;PESCARMONA, Gianpiero;
2008-01-01

Abstract

It has been suggested that iron-deficient rats have lower bone mass than iron-replete animals, but a clear association between bone and iron repletion has not been demonstrated in humans. A growing body of evidences also suggests a relation between lipid oxidation and bone metabolism and between iron metabolism and LDL oxidation. Iron availability to cells also depends on haptoglobin (Hp) phenotypes. Hp has also important antioxidant properties according to its phenotype, hence we evaluate whether Hp phenotype could influence bone density, iron metabolism and lipid oxidation. This cross-sectional study enrolled 455 postmenopausal women affected by osteoporosis (260) or not (195). Bone mineral density, markers of bone and iron metabolism, levels of oxidized LDL (oxLDL) and Hp phenotype were measured in all the subjects. Hp 1.1 and 2.2 frequency was higher and Hp 2.1 was lower in the patients with fragility fractures (80) compared with the controls. We therefore evaluate different Hp phenotypes as risk or protective factors against fragility fracture: Hp 2.1 is a protective factor against fracture while 1.1 is an important and 2.2 a moderate risk factor for fragility fractures. Lower serum iron was associated with elevated transferrin in patients with Hp 1.1; moreover patients had relative iron deficiency compared with the controls and fractured patients had higher level of oxLDL. We found that both iron metabolism and oxLDL varies according to Hp phenotypes and are predictive of bone density. Our data indicate that Hp 2.1 is a protective factor for fragility fractures, depending on its role on iron metabolism and its antioxidant properties.
2008
43(6)
1010
1015
http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T4Y-4T72WXS-2-F&_cdi=4987&_user=525216&_orig=search&_coverDate=12%2F31%2F2008&_sk=999569993&view=c&wchp=dGLzVlz-zSkzS&md5=d0554db824169fa7c71bb856d9ed2f8b&ie=/sdarticle.pdf
Iron; Osteoporosis; Oxidized LDL; Bone density; Haptoglobin; Polymorphism
D'Amelio P; Cristofaro MA; Tamone C; Morra E; Di Bella S; Isaia G; Grimaldi A; Gennero L; Gariboldi A; Ponzetto A; Pescarmona GP; Isaia GC
File in questo prodotto:
File Dimensione Formato  
Role_of_iron_metabolism_and_oxidative_damage_in_postmenopausal_bone_loss.pdf

Accesso riservato

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 519.82 kB
Formato Adobe PDF
519.82 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Role of iron metabolism and oxidative damage in postmenopausal bone loss.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 624.78 kB
Formato Adobe PDF
624.78 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/55973
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 52
  • ???jsp.display-item.citation.isi??? 50
social impact